DR Justin Rubio

DR Justin Rubio

Positions

  • Human genetics and genomics (Neuroscience and infectious diseases)

Overview

OverviewText1

  • After completing a Ph.D. at the Walter and Eliza Hall Institute (WEHI) in 1996 on malaria molecular biology and genomics, he changed fields to research the genetic basis of human neurological diseases at the Wellcome Trust Centre for Human Genetics in Oxford (UK). He was awarded a Howard Florey Post-doctoral Fellowship (Royal Society, London) in 1997 and was instrumental in the discovery of the gene for chorea acanthocytosis. He returned to WEHI in 1999 as Project Leader of the Genes-CRC Tasmanian Multiple Sclerosis (MS) Project and mapped a susceptibility locus for MS in the class I region of the HLA complex.
    In 2004, he was awarded an NHMRC Biomedical Career Development Award and in the same year established The Neurogenetics Laboratory at the Howard Florey Institute. From 2007-2009 he led the ANZgene MS Genetics Consortium’s whole genome scan project, which identified CD40 and CYP27B1 as novel susceptibility genes for MS.

    In 2009, he was awarded an ARC Future Fellowship, which he declined in order to take a position in the Genetics Division at GlaxoSmithKline (GSK, UK). At GSK, he led a programme of genetic and pharmacogenomic research supporting drug development across the pipeline, with a particular focus on the neuroscience and infectious diseases therapy areas. While at GSK, he contributed important pharmacogenetic data to support the regulatory approval of two medicines; dolutegravir for HIV infection and tafenoquine for Plasmodium vivax malaria.

    In 2015, he returned to Australia to take up a joint appointment in human genetics at The University of Melbourne and Florey Institute of Neuroscience and Mental Health. Since returning to academia, he has created a research program in single genomics, which includes multiple sclerosis and motor neuron disease. For this work, he has thus attracted over $0.5 M in philanthropic funding and a similar amount from research collaborations with industry. As Chair of the ANZgene MS Gene   

Affiliation

Member of

  • International Multiple Sclerosis Genetics Consortium. Member 2010 - 2020
  • ANZgene Multiple Sclerosis Genetics Consortium. Chair 2006 - 2020

Publications

Selected publications

Research

Investigator on

Additional Grant Information

  • Other funding awarded:
    • Bethlehem Griffiths Research Foundation (2018, $50k)**
    • BGI Australia Research Collaboration (2017-2019, $340k in-kind)
    • MS Research Australia Incubator grant (2017, $18k)**

    Internal funding awarded:
    • Melbourne Neuroscience Institute, UoM (2016, $40k)
    • Computational Biology Research Initiative, UoM (2016, $20k).

    **Administered by the Florey Institute of Neuroscience and Mental Health   

Awards

Education and training

  • PhD, University of Melbourne 1996
  • BSc (Hons), University of Melbourne 1991
  • BSc, Monash University 1990

Awards and honors

  • Award for most innovative grant application in 2006, Rebecca Cooper Medical Research Foundation, 2006

Linkages

Supervision

Available for supervision

  • N